SteadyMed
develops and commercializes drug product candidates for the subcutaneous treatment of pulmonary arterial hypertension... Read moreSteadyMed
develops and commercializes drug product candidates for the subcutaneous treatment of pulmonary arterial hypertension... Read more
News
Dec 29, 2018
BioPortfolio
SteadyMed: SteadyMed Therapeutics Inc Medical Equipment Deals and Alliances Profile Report Updated 14122018 Prices from USD $250
Aug 31, 2018
PharmiWeb
SteadyMed: United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.
Aug 17, 2018
BioPortfolio
SteadyMed: SteadyMed Therapeutics Inc Medical Equipment Deals and Alliances Profile Report Updated 18072018 Prices from USD $250
Aug 14, 2018
GlobeNewswire
Press Release: SteadyMed : SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results
Aug 02, 2018
Market Exclusive
SteadyMed: SteadyMed Ltd. (NASDAQ:STDY) Files An 8-K Submission of Matters to a Vote of Security Holders
May 15, 2018
PharmiWeb
SteadyMed: SteadyMed Provides Corporate Update and Reports First Quarter 2018 Financial Results
May 08, 2018
4-traders
SteadyMed: The Law Offices of Vincent Wong : Notifies Investors of an Investigation into SteadyMed Ltd. in Connection with the Sale of the Company to United Therapeutics Corporation - STDY
May 03, 2018
4-traders
SteadyMed: Steadymed Ltd : Brodsky & Smith, LLC Announces an Investigation of SteadyMed Ltd.- STDY
May 03, 2018
4-traders
SteadyMed: Brower Piven Commences an Investigation into the Proposed Sale of SteadyMed Ltd.�and Encourages Shareholders to Contact the Firm for Additional Information
May 01, 2018
The Business Journals
SteadyMed: United Therapeutics acquiring rival drugmaker
SteadyMed Competitors
1
2
3
4
5
6
7
8
9
10